Publications

Outcomes of minimally invasive and traditional incisional glaucoma surgery: An IRIS® (intelligent research in sight) registry study

Lin SC. et al, (2026), AJO International, 3, 100246 - 100246

Major Complications following Strabismus Surgery: Nine-year Data from the IRIS® Registry.

Siatkowski RM. et al, (2026), Ophthalmology, 133, 495 - 498

Cataract Progression and Risk Factors for Cataract Surgery after Pars Plana Vitrectomy in Phakic Eyes – an IRIS® Registry Analysis

Wang JC. et al, (2026), Ophthalmology Retina

Strabismus and Strabismus Surgery Reoperation Rates at 1, 3, and 5 Years: Analyses from the IRIS® Registry (Intelligent Research in Sight).

Repka MX. et al, (2026), Ophthalmology, 133, 203 - 213

Current Indications and Outcomes of Penetrating Keratoplasty in the United States

Cui D. et al, (2026), Ophthalmology

Pneumatic Retinopexy for Rhegmatogenous Retinal Detachment Outcomes: IRIS® Registry (Intelligent Research in Sight) Analysis.

Griffin S. et al, (2025), Ophthalmol Retina, 9, 437 - 443

Prevalence and Risk Factors of Blindness Among Primary Angle Closure Glaucoma Patients in the United States: An IRIS Registry Analysis.

Shah SN. et al, (2024), Am J Ophthalmol, 259, 131 - 140

The impact of month and season on the incidence of giant cell arteritis: an Intelligent Research in Sight (IRIS) Registry analysis.

Wladis EJ. et al, (2024), Graefes Arch Clin Exp Ophthalmol, 262, 609 - 614

Shifts in ophthalmic care utilization during the COVID-19 pandemic in the US.

Li C. et al, (2023), Commun Med (Lond), 3

Vitreoretinopathy-Associated Pediatric Retinal Detachment Treatment Outcomes: IRIS® Registry (Intelligent Research in Sight) Analysis.

Belin PJ. et al, (2023), Ophthalmol Sci, 3

Timing of Delayed Retinal Pathology in Patients Presenting with Acute Posterior Vitreous Detachment in the IRIS® Registry (Intelligent Research in Sight).

Vangipuram G. et al, (2023), Ophthalmol Retina, 7, 713 - 720

Loss to Follow-up in Patients with Neovascular Age-Related Macular Degeneration Treated with Anti-VEGF Therapy in the United States in the IRIS® Registry.

Khurana RN. et al, (2023), Ophthalmology, 130, 672 - 683

Multivariable Analyses of Amblyopia Treatment Outcomes from a Clinical Data Registry.

Repka MX. et al, (2023), Ophthalmology, 130, 164 - 166

Emulating VIEW 1 and VIEW 2 Clinical Trial Outcome Data Using the American Academy of Ophthalmology IRIS Registry.

Gallivan MD. et al, (2023), Ophthalmic Surg Lasers Imaging Retina, 54, 6 - 14

Shifts in Care Utilization Patterns During the COVID-19 Pandemic: A High-Dimensional Study of Presentations for Ophthalmic Conditions in the US

Li C. et al, (2023)

Search results (27)